Related Experiment Video
Updated: Apr 5, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Development and Validation of a Distal Embolization Risk Score During Primary Angioplasty in ST-Elevation Myocardial
Massimo Napodano1, Ahmed H Al Mamary1, Filippo Zilio1
1Cardiology Unit, Department of Cardiac Thoracic and Vascular Sciences, University of Padova, Italy.
Insights
A new angiographic risk score predicts distal embolization (DE) risk during primary percutaneous coronary intervention (p-PCI) for ST-elevation myocardial infarction. This simple 4-variable model aids in stratifying patient risk for improved outcomes.
Area of Science:
- Cardiology
- Interventional Cardiology
- Biostatistics
Background:
- Distal embolization (DE) is a complication during primary percutaneous coronary intervention (p-PCI) for ST-elevation myocardial infarction.
- Predicting DE risk is crucial for optimizing patient management and procedural strategies.
Purpose of the Study:
- To develop and validate a novel angiographic risk score for predicting DE risk in patients undergoing p-PCI.
- To identify key angiographic predictors of DE during p-PCI for ST-elevation myocardial infarction.
Main Methods:
- A cohort of 1,200 patients undergoing p-PCI was randomly divided into derivation (n=814) and validation (n=386) groups.
- Logistic regression analysis identified significant risk factors for DE.
- An integer-based risk score was constructed using identified angiographic variables: occlusion pattern, Thrombolysis In Myocardial Infarction (TIMI) Thrombus Score (2-4), reference vessel diameter (≥3.5 mm), and lesion length (>20 mm).
Main Results:
- The final risk score included occlusion pattern, TIMI Thrombus Score, reference vessel diameter, and lesion length.
- DE rates increased significantly with risk strata in both derivation (5.6% low, 15.8% intermediate, 40% high; p<0.0001) and validation cohorts (7.5% low, 12.1% intermediate, 37.9% high; p<0.0001).
- The model demonstrated good predictive performance with C-statistics of 0.70 (derivation) and 0.62 (validation).
Conclusions:
- A simple, 4-variable angiographic risk score effectively predicts the individual risk of DE during p-PCI for ST-elevation myocardial infarction.
- This score can aid clinicians in stratifying patients and potentially modifying procedural approaches to mitigate DE risk.
- The developed score is validated and ready for clinical application in interventional cardiology settings.
Abstract:
This study aims to develop and validate a new angiographic risk score to predict the risk of distal embolization (DE) during primary percutaneous coronary intervention (p-PCI) for ST-elevation myocardial infarction. Study included data from 1,200 patients who underwent p-PCI. The cohort was randomly split into a derivation cohort (n = 814) and a validation cohort (n = 386). Logistic regression was used to examine the relation between risk factors and the occurrence of DE. To each covariate in the model was assigned an integer score based on the regression coefficients. Variables included in the risk score, according to multivariable analysis, were occlusion pattern of infarct-related artery, Thrombolysis In Myocardial Infarction Thrombus Score 2 to 4, reference vessel diameter ≥3.5 mm, and lesion length >20 mm. To each variable was assigned a 0- to +2-point score according to the strength of the statistical association. Rates of DE in low-, intermediate-, and high-risk groups were 5.6%, 15.8%, and 40% in the derivation cohort (p for trend <0.0001; C-statistic 0.70) and 7.5%, 12.1%, and 37.9% in the validation cohort (p for trend <0.0001; C-statistic 0.62), respectively. In conclusion, the individual risk of DE in patients who underwent p-PCI can be predicted using a simple 4-variables model based on angiographic features.
More Related Videos
05:26Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Pulmonary Embolism I: Introduction
Pulmonary Embolism III: Nursing Management
Acute Coronary Syndrome IV: Interprofessional Care